Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523455 · ClinicalTrials.gov registry record · NA
Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training
A NA study, sponsored by University of Mary Hardin-Baylor.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03523455: Clinical Trial NA study, sponsored by University of Mary Hardin-Baylor.
NCT03523455 is a NA study that was terminated before completion, run by University of Mary Hardin-Baylor. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03523455, a NA study, was terminated before completion, sponsored by University of Mary Hardin-Baylor.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Participants are required to undergo a screening and qualification before beginning the study. Once qualified, baseline testing is completed in the laboratory. This testing includes: body composition measurements, a blood draw, questionnaires, a VO2 max test, and a time to exhaustion trial. This testing is repeated during week 4 and week 12. At week 8, subjects complete a blood draw and questionnaires only. During the 12 week period, participants will follow an endurance exercise program in which they will train 4 days per week. This is a double-blind study in which participants are randomized into either the placebo or supplement group. They are instructed to ingest the supplement once a day at breakfast. Diet logs are also monitored throughout the duration of the study with the restriction of no red meat.
Primary Outcome
The primary purpose is to observe the effect of supplementation on fasting total iron levels prior to and after the supplementation period.
Interventions
- OTHER Sugar Pill
- DIETARY_SUPPLEMENT Iron Aid IPS (Iron Protein Succinylate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-11-29 |
| Est. Completion | 2017-11-11 |
| Phase | NA |
Why NCT03523455 stopped before completion
NCT03523455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Sugar Pill is the first listed.
NCT03523455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03523455 about?
NCT03523455 is a clinical study titled "Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training". Participants are required to undergo a screening and qualification before beginning the study. Once qualified, baseline testing is completed in the laboratory. This testing includes: body composition measurements, a blood draw, questionnaires, a VO2 max test, and a time to exhaustion trial. This tes...
What is the current status of trial NCT03523455?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-11-29. Estimated completion is 2017-11-11.
What interventions are being tested in trial NCT03523455?
The interventions under investigation include: Sugar Pill (OTHER), Iron Aid IPS (Iron Protein Succinylate) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03523455?
This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03523455's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI